National Bank Of Canada Repligen Corp Transaction History

National Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$138.78 - $176.51 $138 - $176	-1 Reduced 0.53%	186 $29,000
Q1 2023 Apr 12, 2023	SELL	$154.26 - $198.1 $2,005 - $2,575	-13 Reduced 6.5%	187 $31,000
Q4 2022 Jan 24, 2023	SELL	$162.42 - $220.56 $79,910 - $108,515	-492 Reduced 71.1%	200 $0
Q3 2022 Oct 13, 2022	BUY	$160.42 - $256.21 $80,210 - $128,104	500 Added 260.42%	692 $130,000
Q2 2022 Jul 28, 2022	BUY	$140.68 - $188.02 $3,376 - $4,512	24 Added 14.29%	192 $32,000
Q1 2022 May 05, 2022	SELL	$161.19 - $257.96 $3.51 Million - $5.62 Million	-21,794 Reduced 99.24%	168 $32,000
Q4 2021 Jan 24, 2022	BUY	$247.59 - $304.47 $5.44 Million - $6.69 Million	21,962 New	21,962 $5.82 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.